Orthofix Medical Inc (OFIX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.063x

Based on the latest financial reports, Orthofix Medical Inc (OFIX) has a cash flow conversion efficiency ratio of 0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.48 Million) by net assets ($450.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Orthofix Medical Inc - Cash Flow Conversion Efficiency Trend (1992–2025)

This chart illustrates how Orthofix Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Orthofix Medical Inc for a breakdown of total debt and financial obligations.

Orthofix Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthofix Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Malibu Boats Inc
NASDAQ:MBUU
0.025x
Suzhou Industrial Park Heshun Electric Co Ltd
SHE:300141
-0.022x
CANGO INC. SP.ADR/2 CL.A
F:9C0A
N/A
Inghams Group Ltd
AU:ING
0.549x
Canopy Growth Corp
NASDAQ:CGC
-0.023x
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
0.022x
Light S.A
SA:LIGT3
-0.019x
Jw Pharmac
KO:001060
0.132x

Annual Cash Flow Conversion Efficiency for Orthofix Medical Inc (1992–2025)

The table below shows the annual cash flow conversion efficiency of Orthofix Medical Inc from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see Orthofix Medical Inc market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $450.04 Million $33.35 Million 0.074x +44.55%
2024-12-31 $503.12 Million $25.79 Million 0.051x +167.08%
2023-12-31 $598.73 Million $-45.75 Million -0.076x -123.10%
2022-12-31 $336.86 Million $-11.54 Million -0.034x -162.47%
2021-12-31 $336.93 Million $18.48 Million 0.055x -73.65%
2020-12-31 $356.86 Million $74.27 Million 0.208x +112.87%
2019-12-31 $327.63 Million $32.03 Million 0.098x -34.31%
2018-12-31 $335.40 Million $49.92 Million 0.149x -17.24%
2017-12-31 $296.61 Million $53.34 Million 0.180x +5.99%
2016-12-31 $263.48 Million $44.71 Million 0.170x +13.96%
2015-12-31 $290.31 Million $43.22 Million 0.149x -12.46%
2014-12-31 $299.63 Million $50.96 Million 0.170x -21.53%
2013-12-31 $311.18 Million $67.44 Million 0.217x +671.90%
2012-12-31 $399.10 Million $11.21 Million 0.028x -86.34%
2011-12-31 $315.17 Million $64.78 Million 0.206x +45.61%
2010-12-31 $300.89 Million $42.47 Million 0.141x -32.13%
2009-12-31 $240.27 Million $49.97 Million 0.208x +56.98%
2008-12-31 $202.06 Million $26.77 Million 0.132x +167.45%
2007-12-31 $433.94 Million $21.50 Million 0.050x +138.04%
2006-12-31 $392.63 Million $8.17 Million 0.021x -92.80%
2005-12-31 $368.88 Million $106.67 Million 0.289x +212.66%
2004-12-31 $297.17 Million $27.48 Million 0.092x -29.95%
2003-12-31 $240.78 Million $31.79 Million 0.132x -19.83%
2002-12-31 $177.95 Million $29.30 Million 0.165x +26.93%
2001-12-31 $145.43 Million $18.87 Million 0.130x -67.39%
2000-12-31 $141.51 Million $56.31 Million 0.398x +357.70%
1999-12-31 $97.20 Million $8.45 Million 0.087x +24.90%
1998-12-31 $86.20 Million $6.00 Million 0.070x +5.62%
1997-12-31 $69.80 Million $4.60 Million 0.066x +102.80%
1996-12-31 $67.70 Million $2.20 Million 0.032x -57.48%
1995-12-31 $61.50 Million $4.70 Million 0.076x -59.96%
1994-12-31 $46.10 Million $8.80 Million 0.191x -27.35%
1993-12-31 $37.30 Million $9.80 Million 0.263x +133.18%
1992-12-31 $28.40 Million $3.20 Million 0.113x --

About Orthofix Medical Inc

NASDAQ:OFIX USA Medical Devices
Market Cap
$478.12 Million
Market Cap Rank
#12760 Global
#2976 in USA
Share Price
$11.91
Change (1 day)
+1.28%
52-Week Range
$10.34 - $16.23
All Time High
$67.71
About

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more